Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma, (Front. Oncol, (2022), 12, (632042), 10.3389/fonc.2022.632042)

Abstract

In the published article, there was an error in the PDF page header. Instead of “Liu et al”, it should be “Deng et al.”. In the published article, there was an error in affiliation 1. Instead of “1Department of Otolaryngology and Geriatric Medicine, Biobank, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen Second People’s Hospital, Shenzhen, China, 2Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Second People’s Hospital, Shenzhen, China”, it should be “Department of Otolaryngology and Geriatric Medicine, Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen University, Shenzhen, China”. In the published article, there was an error in the Funding statement. One funding source was carelessly missed with the code “ZDSYS20190902093401689”. The funding statement for the Shenzhen STIC Research Foundation should be combined with Shenzhen Science and Technology Innovation Committee since they stand for the same funding agency. The correct Funding statement appears below.